You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com
You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our German operations at www.oncopeptides.de
Change Language
At SEB's Annual Healthcare Seminar 2022 Jakob Lindberg, CEO Oncopeptides, participated in a fire side chat with Dr. Christopher Uhde, Pharma/Biotec equity research at SEB.
This fire side chat was recorded on November 23, 2022.
